Back to Aberdeen Group plc Aberdeen Group plc

LXEOLXEO
2 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in LEXEO THERAPEUTICS INC

Aberdeen Group plc holds 675,092 shares of LXEO (LEXEO THERAPEUTICS INC), worth $3.1M as of 2026-Q2. The position was increased (+174.5% shares). LXEO represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$3.1M

Current Shares

675,092

Total Value Change

+$1.7M

Total Shares Change

+429,188

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
675,092
+174.5%
$3.1M0.0%$4.66
43
2026-Q1
New
245,904
-
$1.4M0.0%$7.07
35

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used